Results 231 to 240 of about 29,136 (254)

Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains

Proceedings of the National Academy of Sciences of the United States of America, 2021
Sang Moo Kang, Chunhong Dong, Bao-Zhong Wang   +2 more
exaly  

Utilising salmonella to deliver heterologous vaccine antigen

2010
Live attenuated Salmonella vectors provide a unique alternative in terms of antigen presentation by acting as a vector for heterologous antigens. The efficiency of any live bacterial vector rests with its ability to present sufficient foreign antigen to the human or animal immune system to initiate the desirable protective immune response.Salmonella ...
openaire   +1 more source

Comparing Heterologous and Homologous COVID-19 Vaccination: A Longitudinal Study of Antibody Decay

Viruses, 2023
Aurora Diotallevi, Anna Casabianca, Mauro Magnani   +2 more
exaly  

Does ChAdOx1-S and BNT162b2 heterologous prime-boost vaccination trigger higher rates of vaccine-related adverse events?

IJID Regions, 2023
Hani Jokhdar, Alhan Haji, Khaled Alabdulkareem   +2 more
exaly  

Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants

Vaccines, 2022
Honglin Chen, Danlei Liu, Kwok-Yung Yuen   +2 more
exaly  

Evaluation of Antibody Response to Heterologous Prime–Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study

Vaccines, 2021
Federico Meloni, Del Giacco, Marcello Campagna   +2 more
exaly  

Heterologous Prime Boost Vaccine

2022
WOLLMANN GUIDO, DAS KRISHNA, DEROUAZI MADIHA, BELNOUE ELODIE, ELBERS KNUT   +4 more
openaire   +2 more sources

Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial

EBioMedicine, 2022
Sebastian Schoenherr, Alessandro Sette, Wegene Borena   +2 more
exaly  

Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19—BNT162b2 mRNA Vaccination

Viruses, 2022
François Carlier, François Mullier, Patrick Evrard   +2 more
exaly  

Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2

EBioMedicine, 2022
Klaus Ueberla, Kilian Schöber, Nina Körber   +2 more
exaly